新乡医学院学报2024,Vol.41Issue(10) :925-929.DOI:10.7683/xxyxyxb.2024.10.005

含α-Arrestin结构域蛋白3在脑胶质瘤组织中的表达及其临床意义

Expression of α-Arrestin domain-containing protein 3 in brain glioma tissues and its clinical significance

郭同轩 于如同 郭威才 汪敏行 刘重友
新乡医学院学报2024,Vol.41Issue(10) :925-929.DOI:10.7683/xxyxyxb.2024.10.005

含α-Arrestin结构域蛋白3在脑胶质瘤组织中的表达及其临床意义

Expression of α-Arrestin domain-containing protein 3 in brain glioma tissues and its clinical significance

郭同轩 1于如同 2郭威才 1汪敏行 1刘重友1
扫码查看

作者信息

  • 1. 徐州医科大学神经系统疾病研究所,江苏 徐州 221000
  • 2. 徐州医科大学附属医院神经外科,江苏 徐州 221000
  • 折叠

摘要

目的 探讨含α-Arrestin结构域蛋白3(ARRDC3)基因在人脑胶质瘤组织中的表达水平及其临床意义.方法 使用中国脑胶质瘤基因组图谱(CGGA)数据库与癌症基因组图谱(TCGA)数据库分析脑胶质瘤患者的临床资料及其基因表达情况.收集2018年1月至2021年12月徐州医科大学附属医院神经外科收治的9例原发性脑胶质瘤患者的脑胶质瘤组织标本,免疫组织化学实验检测ARRDC3在不同分级胶质瘤中的表达水平.应用非参数检验分析ARRDC3在不同分子类型、不同分级胶质瘤中的表达水平;通过Kaplan-Meier生存曲线分析ARRDC3表达对脑胶质瘤患者生存时间的影响;应用单因素和多因素Cox回归分析ARRDC3的表达对胶质瘤患者预后的影响.结果 CGGA和TCGA数据库中的数据显示,Ⅱ、Ⅲ、Ⅳ级人脑胶质瘤中ARRDC3基因的表达逐渐升高(P<0.05);免疫组织化学染色实验结果与其一致.异柠檬酸脱氢酶(IDH)野生型胶质瘤患者中,ARRDC3基因表达水平显著高于IDH突变型患者(P<0.05);ARRDC3高表达组患者的中位生存期显著短于ARRDC3低表达组(P<0.05);多因素Cox回归分析结果显示,年龄、IDH突变状态、放射治疗、ARRDC3表达情况是人脑胶质瘤患者预后的危险因素(P<0.05).结论 人脑胶质瘤组织中ARRDC3的相对表达量随着肿瘤组织病理分级的上升逐渐升高;ARRDC3低表达的脑胶质瘤患者的预后明显好于高表达患者;ARRDC3可能成为预测胶质瘤患者预后的指标之一.

Abstract

Objective To explore the expression level and clinical significance of α-Arrestin domain-containing protein 3(ARRDC3)gene in human brain glioma tissues.Methods Clinical data and gene expression of patients with brain glioma were analyzed using the Chinese Glioma Genome Atlas(CGGA)database and the Cancer Genome Atlas(TCGA)database.Brain glioma specimens were collected from 9 patients with primary brain gliomas treated in the Department of Neurosurgery,the Affiliated Hospital of Xuzhou Medical University from January 2018 to December 2021.The expression levels of ARRDC3 in gliomas of different grades were detected through immunohistochemical experiments.The expression levels of ARRDC3 in gliomas with different molecular types and grades were analyzed by using thenon-parametrictest.The effect of ARRDC3 expression on the survival time of brain glioma patients was analyzed by using the Kaplan-Meier survival curve,while the effect of ARRDC3 expression on prognosis of glioma patients was analyzed by using univariate and multivariate Cox regression models.Results Data in the CGGA and TCGA databases showed that the expression of ARRDC3 in the grade Ⅱ,Ⅲ and Ⅳhuman brain gliomas increased gradually(P<0.05).The results of immunohistochemical staining experiments were consistent with the above results(P<0.05).The ARRDC3 expression in isocitrate dehydrogenase(IDH)wild type glioma patients was significantly higher than that in IDH mutant glioma patients(P<0.05).The overall survival of the patients with high ARRDC3 expression was significantly shorter than that of the patients with low ARRDC3 expression(P<0.05).Multivariate Cox regression analysis revealed that age,IDH mutation state,radiotherapy and ARRDC3 expression were risk factors for prognosis of human brain glioma patients(P<0.05).Conclusion With the pathological grade rising gradually,the relative expression level of ARRDC3 in human brain glioma tissues increases gradually.The prognosis of brain glioma patients with low expression of ARRDC3 is significantly better than that of patients with high expression of ARRDC3.ARRDC3 can be used as a prognostic factor for glioma patients.

关键词

脑胶质瘤/含α-Arrestin结构域蛋白3/基因表达

Key words

brain glioma/α-Arrestin domain-containing protein 3/gene expression

引用本文复制引用

基金项目

国家自然科学基金资助项目(82072796)

江苏省重点研发计划项目(BE2020642)

徐州市重点研发计划资助项目(KC22103)

出版年

2024
新乡医学院学报
新乡医学院

新乡医学院学报

CSTPCD
影响因子:0.999
ISSN:1004-7239
参考文献量3
段落导航相关论文